Valter Bergant (@ValterBergant) header
Valter Bergant (@ValterBergant) profile picture

Deciphering virus-host interactions and their implications for antiviral treatments @PichlmairL @TU_Muenchen

Institute of Virology, Munich
Joined May 2015
We are looking for a postdoc with a strong backbround in bioinformatics and/or machine learning to join our lab! Contact me if you are interested.. or retweet.. or just come and talk to me #ISMBECCB2023 next week in Lyon! I will be at the iRNA COSI 26-27 July
1
19
2
32
9,186
Last day of early bird registration for the 31st @GesVirologie meeting, 30.3. – 2.4.2022 @TU_Muenchen! Also excited to announce that I will be presenting our awesome research on cross-functional host-directed antivirals against #SARSCoV2 and #COVID19!
1
While not unique for SARS-CoV-2, it is always humbling to read: "At 8 h after infection, viral mRNAs comprise almost 80% of the mRNAs in infected cells ...". Not easy to outrun, either for host response or treatment.
Our paper is now out @nature where we uncover the mechanisms SARS-CoV-2 is employing to suppress host protein synthesis and disarm host defenses. nature.com/articles/s41586-0… This was another great collaboration with the IIBR and a huge team effort of my outstanding group 1/n
1
2
Inhibitors of nucleotide biosynthesis as host-directed antivirals against SARS-CoV-2, targeting virocells based on metabolic requirements. The virus-host metabolic interface can become a bottleneck and may further sensitize against DAAs.
A study in @Nature found that combining pyrimidine biosynthesis inhibitors with antiviral nucleoside analogues synergistically inhibits SARS-CoV-2 infection against emerging strains of SARS-CoV-2, suggesting a clinical path forward. go.nature.com/3ru11o2
1
1
Valter Bergant retweeted
Proud to be among the recipients of #ERCPoC! Big congrats to @ValterBergant et al. for the fantastic work! Exciting year ahead!
5
1
29